NCT01753414View on ClinicalTrials.gov

Radical Resection Vs. Ablative Stereotactic Radiotherapy in Patients With Operable Stage I NSCLC

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

December 31, 2012

Primary Completion Date

April 3, 2023

Study Completion Date

January 31, 2026

Conditions
Non-small Cell Lung Cancer
Interventions
RADIATION

Stereotactic Body Radiation Therapy (SBRT)

Daily fractions

PROCEDURE

Surgery

Radical resection

Trial Locations (4)

10021

Chinese Academy of Medical Science, Beijing

200032

Shanghai Cancer Center/Fudan University, Shanghai

250117

Shandong Cancer Hospital, Jinan, Shangdong

310022

Zhejiang Cancer Hospital, Hangzhou, Zhejiang

Sponsors

Collaborators (1)

Varian Medical Systems
All Listed Sponsors
collaborator

Varian Medical Systems

INDUSTRY

lead

Radiation Therapy Oncology Group

NETWORK